Asparia Glycomics is now a registered supplier on Scientist.com, an online marketplace that connects research organizations with specialized service providers across the life sciences. Scientist.com operates as an intermediary platform where pharmaceutical companies, biotech firms, and academic institutions can search for and engage with contract research organizations that offer the specific capabilities they need.
Through this registration, researchers can now find Asparia when searching the marketplace for custom carbohydrate synthesis services. Our listing includes our full range of capabilities: the synthesis of complex glycans, oligosaccharides, glycoconjugates, glycolipids, and glycopeptides. We also offer Tumor-Associated Carbohydrate Antigens, which are carbohydrate structures found on the surface of cancer cells and are increasingly used in the development of cancer vaccines and immunotherapies.
The platform simplifies the procurement process for research services. Instead of reaching out to multiple providers individually, researchers can submit their project requirements through Scientist.com and receive quotes from relevant suppliers. The system handles the administrative aspects of the transaction, including contracts and payments, which can be particularly useful for large organizations with complex procurement procedures.
For our part, being on Scientist.com gives us visibility among a broader international audience of potential clients. Many biotech and pharma companies already use the platform as their primary channel for outsourcing research work, so having a presence there means we can be discovered by teams who might not have found us otherwise. Our synthesis services range from milligram quantities for early-stage research to gram-scale production for more advanced studies, and we work with both natural carbohydrate structures and modified or synthetic variants designed for specific applications.

